ID

22332

Beschreibung

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Stichworte

Versionen (1)
  1. 30.05.17 30.05.17 -
Hochgeladen am

30. Mai 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Englisch

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulare  
Pregnancy Information
Beschreibung

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
Beschreibung

Pregnancy

Datentyp

integer

Alias
UMLS CUI [1]
C0032961
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
Beschreibung

Female of childbearing potential

Datentyp

integer

Alias
UMLS CUI [1]
C1960468
Study Conclusion
Beschreibung

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Did the patient complete the study as planned?
Beschreibung

Study completion

Datentyp

boolean

Alias
UMLS CUI [1]
C2826674
If "no", mark the one most appropriate category
Beschreibung

Specification

Datentyp

integer

Alias
UMLS CUI [1]
C2348235
Please specify "Other"
Beschreibung

Other diseases

Datentyp

text

Alias
UMLS CUI [1]
C2359476
Comments on reason for withdrawal:
Beschreibung

Withdrawal

Datentyp

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
Date of Withdrawal
Beschreibung

Date of Withdrawal

Datentyp

date

Maßeinheiten
  • dd/mm/yyyy
Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0011008
dd/mm/yyyy
Time of Withdrawal
Beschreibung

Time of Withdrawal

Datentyp

time

Maßeinheiten
  • hr:min
Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0040223
hr:min
Date of Final Dose:
Beschreibung

therapy end date

Datentyp

date

Maßeinheiten
  • dd/mm/yyyy
Alias
UMLS CUI [1]
C1531784
dd/mm/yyyy
Time of Final Dose
Beschreibung

Pharmaceutical Preparations

Datentyp

time

Maßeinheiten
  • hr:min
Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1522314
hr:min
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Pregnancy Information Study Conclusion Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Item
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
integer
C0032961 (UMLS CUI [1])
Pregnancy
Code List
Did patient become pregnant during the study? (mark one box below) -> If "yes" record details on Pregnancy Notification Form
CL Item
Not applicable (not of childbearing potential) (1)
CL Item
No (2)
CL Item
Yes (3)
Item
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
integer
C1960468 (UMLS CUI [1])
Female of childbearing potential
Code List
Did the female partner of a male patient become pregnant during the study? (mark one box below) --> if "yes" record details on Pregnancy Notification Form.
CL Item
Not applicable (subject is female, female partner not of childbearing potential or female partner) (1)
CL Item
No (2)
CL Item
Yes (3)
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Study completion
Item
Did the patient complete the study as planned?
boolean
C2826674 (UMLS CUI [1])
Item
If "no", mark the one most appropriate category
integer
C2348235 (UMLS CUI [1])
Specification
Code List
If "no", mark the one most appropriate category
CL Item
Adverse Event (complete Adverse Event Form) (1)
CL Item
Insufficient therapeutic effect (2)
CL Item
Deviation from Protocol (including non-compliance) (3)
CL Item
Lost to Follow-Up (4)
CL Item
Other (5)
Other diseases
Item
Please specify "Other"
text
C2359476 (UMLS CUI [1])
Withdrawal
Item
Comments on reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Date of Withdrawal
Item
Date of Withdrawal
date
C2349954 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Time of Withdrawal
Item
Time of Withdrawal
time
C2349954 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
therapy end date
Item
Date of Final Dose:
date
C1531784 (UMLS CUI [1])
Pharmaceutical Preparations
Item
Time of Final Dose
time
C0013227 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video